LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance

U.S. Markets open in 3 hrs 33 mins

Eli Lilly and Company (LLY)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
82.55+1.48 (+1.83%)
At close: 4:01PM EST
People also watch
BMYMRKABTGSKJNJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close81.07
Open81.38
Bid0.00 x
Ask0.00 x
Day's Range81.14 - 82.88
52 Week Range64.18 - 83.79
Volume6,193,454
Avg. Volume5,333,511
Market Cap86.6B
Beta0.24
PE Ratio (TTM)32.02
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (2.57%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist13 hours ago

    Eli Lilly & Co.’s Revenues in 4Q16

    Eli Lilly & Co.'s (LLY) top line rose 7% to ~$5.8 billion for 4Q16, driven by volume growth of pharmaceutical products such as Erbitux, Trulicity, Humalog, and Cyramza.

  • American City Business Journals16 hours ago

    In 'groundbreaking' deal, Harvard Pilgrim negotiates contracts to save on two pricey drugs

    Harvard Pilgrim Health Care has negotiated new payment contracts with two pharmaceutical companies for expensive drugs, progressing a new kind of payment model that could save millions of dollars down the line. If not, the insurer receives a rebate from the pharmaceutical company, which trickles down into more stable premiums for members. “If you think about it, this is considered groundbreaking but it shouldn’t be,” said Michael Sherman, chief medical officer and senior vice president for health services at Harvard Pilgrim.

  • Investopedia20 hours ago

    Amgen Signs Value-Based Deal for Enbrel

    The deal serves a dual purpose: Deliver better value to patients and preserve the drug's market share.